2. Academic Validation
  3. Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells

Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells

  • Nat Biomed Eng. 2024 Dec 27. doi: 10.1038/s41551-024-01309-0.
Nan Li # 1 2,  Hao Qin # 1,  Fei Zhu # 1,  Hao Ding 1,  Yang Chen 1 2,  Yixuan Lin 1 2,  Ronghui Deng 1,  Tianyu Ma 1,  Yuanyuan Lv 1,  Changhao Xiong 1,  Rong Li 1,  Yaohua Wei 1,  Jian Shi 1,  Hanqing Chen 3,  Yuliang Zhao 1 4,  Guangbiao Zhou 5,  Hua Guo 5,  Mengyao Lv 5,  Yongfang Lin 5,  Bing Han 6,  Guangjun Nie 7 8,  Ruifang Zhao 9 10
Affiliations

Affiliations

  • 1 CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P. R. China.
  • 2 Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, P. R. China.
  • 3 Department of Nutrition and Food Hygiene, School of Public Health, Capital Medical University, Beijing, P. R. China.
  • 4 School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou, P. R. China.
  • 5 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • 6 Department of Orthodontics, Cranial-Facial Growth and Development Center, Peking University School and Hospital of Stomatology, Beijing, P. R. China. kqbinghan@bjmu.edu.cn.
  • 7 CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P. R. China. niegj@nanoctr.cn.
  • 8 Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, P. R. China. niegj@nanoctr.cn.
  • 9 CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, P. R. China. zhaorf@nanoctr.cn.
  • 10 Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, P. R. China. zhaorf@nanoctr.cn.
  • # Contributed equally.
PMID: 39730914 DOI: 10.1038/s41551-024-01309-0
Abstract

The development of prophylactic Cancer vaccines typically involves the selection of combinations of tumour-associated antigens, tumour-specific antigens and neoantigens. Here we show that membranes from induced pluripotent stem cells can serve as a tumour-antigen pool, and that a nanoparticle vaccine consisting of self-assembled commercial adjuvants wrapped by such membranes robustly stimulated innate immunity, evaded antigen-specific tolerance and activated B-cell and T-cell responses, which were mediated by epitopes from the abundant number of antigens shared between the membranes of tumour cells and pluripotent stem cells. In mice, the vaccine elicited systemic antitumour memory T-cell and B-cell responses as well as tumour-specific immune responses after a tumour challenge, and inhibited the progression of melanoma, colon Cancer, breast Cancer and post-operative lung metastases. Harnessing antigens shared by pluripotent stem cell membranes and tumour membranes may facilitate the development of universal Cancer vaccines.

Figures
Products